Literature DB >> 17061225

Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART.

M Accorinti1, M P Pirraglia, R Corradi, C Corsi, C Fabiani, P Pivetti-Pezzi.   

Abstract

PURPOSE: To report the changing patterns of ocular manifestations in human immunodeficiency virus (HIV) seropositive patients treated with highly active antiretroviral therapy (HAART).
METHODS: The clinical charts of HIV seropositive patients, 735 examined from 1997 to 2003 and treated with HAART for at least 2 months (Group 1), and 838 untreated examined from 1988 to 1995 (Group 2), were reviewed to assess the frequency of ocular manifestations.
RESULTS: HIV-related retinal microangiopathy and opportunistic retinal infections (cytomegalovirus retinitis and toxoplasmic retinochoroiditis) were significantly higher in Group 2 than 1 (p<0.0001), while in patients treated with HAART a statistically significant increase in the frequency of chalazion (p<0.0001), diabetic and hypertensive retinopathy (p<0.0001), lipid arc of the cornea (p<0.0001), cataract and glaucoma (p<0.0001), and uveitis (p=0.026) was observed.
CONCLUSIONS: HAART therapy has induced a dramatic decrease in the incidence of HIV-related microangiopathy and opportunistic retinal infection and the occurrence of new lesions related both to the metabolic alterations induced by HAART and to immune reconstitution, such as uveitis.

Entities:  

Mesh:

Year:  2006        PMID: 17061225     DOI: 10.1177/112067210601600511

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  5 in total

1.  Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern Ethiopia.

Authors:  Anteneh Amsalu; Kindie Desta; Demiss Nigussie; Demoze Delelegne
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

2.  Visual Impairment and Eye Diseases in HIV-infected People in the Antiretroviral Therapy (ART) Era in Rakai, Uganda.

Authors:  Jian-Yu E; Zhengfan Wang; Joseph Ssekasanvu; Beatriz Munoz; Sheila West; James Ludigo; Ronald Gray; Gertrude Nakigozi; Xiangrong Kong
Journal:  Ophthalmic Epidemiol       Date:  2020-07-14       Impact factor: 1.648

3.  HIV-infected individuals on long-term antiretroviral therapy are at higher risk for ocular disease.

Authors:  E Schaftenaar; N S Khosa; G S Baarsma; C Meenken; J A McINTYRE; A D M E Osterhaus; G M G M Verjans; R P H Peters
Journal:  Epidemiol Infect       Date:  2017-05-19       Impact factor: 4.434

4.  A Case of Proliferative Diabetic Retinopathy with HIV Infection in Which HAART Possibly Influenced the Prognosis of Visual Function.

Authors:  Takakuni Kitagaki; Takaki Sato; Junko Hirai; Daisaku Kimura; Keigo Kakurai; Masanori Fukumoto; Kensuke Tajiri; Takatoshi Kobayashi; Teruyo Kida; Shota Kojima; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2016-11-17

Review 5.  Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy - An update.

Authors:  Sridharan Sudharshan; Nivedita Nair; Andre Curi; Alay Banker; John H Kempen
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.